| Primary |
| Constipation |
20.0% |
| Diabetes Mellitus |
20.0% |
| Dyslipidaemia |
20.0% |
| Hypertension |
20.0% |
| Reflux Oesophagitis |
20.0% |
|
| Cardiac Failure |
60.0% |
| Local Swelling |
20.0% |
| Peripheral Coldness |
20.0% |
|
| Secondary |
| Product Used For Unknown Indication |
33.9% |
| Dyspepsia |
9.4% |
| Drug Use For Unknown Indication |
8.7% |
| Helicobacter Infection |
7.1% |
| Anxiety |
5.5% |
| Chest Pain |
4.7% |
| Helicobacter Gastritis |
4.7% |
| Prophylaxis |
4.7% |
| Cardiovascular Disorder |
3.9% |
| Gastrooesophageal Reflux Disease |
3.1% |
| Osteoporosis |
2.4% |
| Coronary Artery Disease |
1.6% |
| Dyskinesia |
1.6% |
| Extrapyramidal Disorder |
1.6% |
| Hypertension |
1.6% |
| Neuropathy Peripheral |
1.6% |
| Psychotic Disorder |
1.6% |
| Hormone Replacement Therapy |
0.8% |
| Insomnia |
0.8% |
| Multiple Sclerosis |
0.8% |
|
| Multiple Drug Overdose Intentional |
9.4% |
| Tetany |
9.4% |
| Drug Interaction |
6.3% |
| Extrapyramidal Disorder |
6.3% |
| Hyperkalaemia |
6.3% |
| Pseudomembranous Colitis |
6.3% |
| Toxicity To Various Agents |
6.3% |
| Ventricular Arrhythmia |
6.3% |
| Vision Blurred |
6.3% |
| Vomiting |
6.3% |
| Acute Generalised Exanthematous Pustulosis |
3.1% |
| Dissociative Disorder |
3.1% |
| Drug Exposure During Pregnancy |
3.1% |
| Impaired Healing |
3.1% |
| Memory Impairment |
3.1% |
| Purpura |
3.1% |
| Renal Failure |
3.1% |
| Swollen Tongue |
3.1% |
| Torsade De Pointes |
3.1% |
| Trismus |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
35.6% |
| Rheumatoid Arthritis |
10.7% |
| Hypertension |
8.5% |
| Drug Use For Unknown Indication |
8.2% |
| Prophylaxis |
4.5% |
| Gastrooesophageal Reflux Disease |
3.9% |
| Pain |
3.6% |
| Diabetes Mellitus |
3.0% |
| Adverse Event |
2.6% |
| Asthma |
2.3% |
| Depression |
2.3% |
| Crohn's Disease |
2.2% |
| Constipation |
2.0% |
| Premedication |
1.9% |
| Diffuse Large B-cell Lymphoma |
1.7% |
| Plasma Cell Myeloma |
1.6% |
| Osteoporosis |
1.5% |
| Type 2 Diabetes Mellitus |
1.4% |
| Dyspepsia |
1.3% |
| Prostate Cancer |
1.2% |
|
| Weight Increased |
13.6% |
| Weight Decreased |
9.3% |
| Vomiting |
7.9% |
| Renal Failure Acute |
6.4% |
| Myocardial Infarction |
5.7% |
| Toxic Epidermal Necrolysis |
5.7% |
| Nausea |
4.3% |
| Pain In Extremity |
4.3% |
| Somnolence |
4.3% |
| Stomatitis |
4.3% |
| Type 2 Diabetes Mellitus |
4.3% |
| Haemoglobin Decreased |
3.6% |
| Hypoglycaemia |
3.6% |
| Nephrotic Syndrome |
3.6% |
| Pneumonia |
3.6% |
| Renal Failure |
3.6% |
| Tremor |
3.6% |
| Interstitial Lung Disease |
2.9% |
| Lung Disorder |
2.9% |
| Myopathy |
2.9% |
|
| Interacting |
| Helicobacter Gastritis |
100.0% |
|
| Drug Interaction |
50.0% |
| Substance-induced Psychotic Disorder |
50.0% |
|
